Evfraxy 60 mg/ml, Injektionslösung in einer Fertigspritze

7680701400014 CH-70140 Injektionslösung

No image available

Article details

Package size
1
Selling units
1
Measure
Fertigspritze(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
12/09/2026
Patient information leaflet
Français
12/09/2026
Patient information leaflet
Italien
12/09/2026
Summary of Product Characteristics
Allemand
01/05/2026
Summary of Product Characteristics
Français
01/05/2026
Summary of Product Characteristics
Italien
01/05/2026

Detailed composition

Substance Quantity Type Category
denosumabum
60.0 MG Substance Wirkstoff (Principe actif)
natrii acetas trihydricus
- Substance HNIDK
natrium
0.3 MG Substance HBESI
acidum aceticum glaciale
- Substance HNIDK
sorbitolum
47.0 MG Substance HBESI
polysorbatum 20
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
acidum aceticum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 206.10
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/05/2026

Authorization holder

Medius AG

4132 Muttenz

Authorization information

Swissmedic authorization number
70140
Drug name
Evfraxy, Injektionslösung in einer Fertigspritze
Galenic form
INLFS
ATC Code
M05BX04
Authorization status
Z
Dispensing category
B
First authorization
18/11/2025
Authorization expiration date
17/11/2030
IT Number
07.99.0.
Domain
Human medicine
Field of application
Osteoporose

Package details

Description (FR)
EVFRAXY 60 mg/ml sol inj ser pré 1 pce
Description (DE)
EVFRAXY 60 mg/ml Inj Lös in einer Fertigspr 1 Stk
Market launch
01/05/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data